What question did this study set out to answer?

To examine the transition of non-vitamin K antagonist oral anticoagulants from emerging alternatives to established standard therapies in anticoagulation care.

January 1, 2014Thrombosis and HaemostasisOpen Access

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

View Full Paper

Ask AI

Bookmark

Key result

This text is a journal masthead and does not contain clinical study results.

Key Points

To examine the transition of non-vitamin K antagonist oral anticoagulants from emerging alternatives to established standard therapies in anticoagulation care.
Expert editorial synthesis evaluating clinical adoption, literature conventions, and terminology surrounding oral anticoagulant therapies.
Non-vitamin K antagonist oral anticoagulants have largely superseded traditional vitamin K antagonists as standard-of-care treatments across major thromboembolic indications.
The continued designation of these established agents as 'novel' or 'new' no longer reflects their decade-long clinical maturity and widespread real-world adoption.

Implication

Editorial review highlights the established clinical role of non-vitamin K antagonist oral anticoagulants in cardiovascular therapy, suggesting that novel terminology is outdated.

Abstract

Note: The editorial process for this paper was fully handled by Prof Christian Weber, Editor in Chief.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Caterina et al. (2014) studied this question. This text is a journal masthead and does not contain clinical study results.

synapsesocial.com/papers/6a7c96fdf1688b70c0610f89 https://doi.org/10.1160/th14-03-0228

View Full Paper

Ask AI

Bookmark

Implication

Editorial review highlights the established clinical role of non-vitamin K antagonist oral anticoagulants in cardiovascular therapy, suggesting that novel terminology is outdated.

Abstract

Note: The editorial process for this paper was fully handled by Prof Christian Weber, Editor in Chief.

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

Key Points

Implication

Abstract

Discussion

Cite This Study

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading